10x Genomics Inc
(FRA:1KJ)
€
38.2
-1.925 (-4.8%)
Market Cap: 4.88 Bil
Enterprise Value: 4.47 Bil
PE Ratio: 0
PB Ratio: 6.93
GF Score: 60/100 10X Genomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 07:50PM GMT
Release Date Price:
€153.45
(+1.76%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Good afternoon, everyone. I'm Matt Sykes, Senior Research Analyst for Life Science Tools & Diagnostics at Goldman. And I have the pleasure of welcoming the 10x Genomics management team to present to us today. We have Serge Saxonov, the Chief Executive Officer; and Justin McAnear, the Chief Financial Officer. Serge, Justin, thanks so much for being here. We really appreciate it.
Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director
Thanks for having us. Thank you.
Questions & Answers
Matthew Carlisle Sykes;Serge Saxonov
Goldman Sachs Group, Inc., Research Division - Research Analyst;10x Genomics, Inc. - Co
Maybe I'll turn it over to your first, Serge, to kind of set the stage a little bit, talk about maybe the most recent quarter, expectations for the year, but just also some of the key drivers and things that you want to -- can be top of mind for investors for 10x?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot